Repeat administration of high dose melphalan in relapsed myeloma.

At a median time of 20 months following high dose melphalan for myeloma, 29 patients relapsed and were treated with induction chemotherapy to maximum response followed by a second course of high dose melphalan. The majority (90%) of patients received 200 mg m-2 with an autologous bone marrow transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansi, J. L., Cunningham, D., Viner, C., Ellis, E., Meldrum, M., Milan, S., Gore, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968739/
https://www.ncbi.nlm.nih.gov/pubmed/8217614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968739/
https://www.ncbi.nlm.nih.gov/pubmed/8217614

Ejemplares similares